I. SCOPE AND METHODOLOGY II. REPORT SYNOPSIS Introduction Liposomes Segmentation of Liposomes Exhibit 1: Segmentation of Global Liposomes Market by Application (Therapeutic, Cosmetic and Other) Segmentation of Liposomes by Therapeutic Application Exhibit 2: Segmentation by Therapeutic Application Definitions Liposomes Market Application- Segments Therapeutics Cosmetics Other Applications of Liposomes Agro-Food Paints (Water Based, Resins, Self Healing Paints) Neutraceuticals Diagnostics Therapeutics- Types Liposomal Antifungal Drugs Liposomal Anticancer drugs Liposomal Ophthalmic Other Therapeutic Applications of Liposomes Preparation of Liposomes Global Market Analysis Exhibit 3: Liposomes- Global Value Market Estimations & Predictions (2005- 2015) in US$ Billion Analysis by Geographic Region Development of ‘Intelligent’ Liposomes for Effective Drug Delivery in Medical Applications Global Market Analysis - Liposomal Therapeutics Exhibit 4: Liposomal Therapeutic - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 5: Liposomal Therapeutic - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Liposomal Cosmetics Using Liposomes for Cosmetics Delivery Global Market Analysis - Liposomal Cosmetics Exhibit 6: Liposomal Cosmetic - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 7: Liposomal Cosmetic - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Other Global Market Analysis – Other Applications of Liposomes Exhibit 8: Other Applications of Liposomes - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 9: Other Applications of Liposomes - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Liposomal Therapeutic Analysis by Geographic Region Antifungal Application of Liposomes to Combat Fungal Infections Analysis of Global Market-Liposomal Antifungal Drugs Exhibit 10: Liposomal Antifungal Drugs - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 11: Liposomal Antifungal Drugs - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Anticancer Global Market Analysis-Liposomal Anticancer Drugs Exhibit 12: Liposomal Anticancer Drugs - Global Value Market Estimations & Predictions (2005 - 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 13: Liposomal Anticancer Drugs - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Ophthalmic Global Market Analysis-Liposomal Ophthalmic Exhibit 14: Liposomal Ophthalmic - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 15: Liposomal Ophthalmic - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Other Global Market Analysis-Other Therapeutic Liposomes Exhibit 16: Liposomes in Other Therapeutic Areas - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 17: Liposomes in Other Therapeutic areas - Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World Exhibit 18: List of Major Global Companies Regional Market Analysis North America North American Market Analysis- Liposomes Exhibit 19: Liposomes - North American Value Market Estimations & Predictions (2005 -2015) in US$ Million Analysis by Geographic Region Liposomal Therapeutics Market Analysis- Liposomal Therapeutics Exhibit 20: Liposomal Therapeutic - North American Value Market Estimations and Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 21: Liposomal Therapeutic - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Liposomal Cosmetics Market Analysis- Liposomal Cosmetics Exhibit 22: Liposomal Cosmetic - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 23: Liposomal Cosmetic - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Other Market Analysis- Other Applications of Liposomes Exhibit 24: Other Applications of Liposomes - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 25: Other Applications of Liposomes - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Liposomal Therapeutic Analysis by Geographic Region Antifungal Market Analysis- Liposomal Antifungal Drugs Exhibit 26: Liposomal Antifungal Drugs - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 27: Liposomal Antifungal Drugs - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Anticancer Market Analysis- Liposomal Anticancer Drugs Exhibit 28: Liposomal Anticancer Drugs - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 29: Liposomal Anticancer Drugs - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Ophthalmic Market Analysis- Liposomal Ophthalmics Exhibit 30: Liposomal Ophthalmic - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 31: Liposomal Ophthalmic - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Other Market Analysis- Liposomes in Other Therapeutic areas Exhibit 32: Liposomes in Other Therapeutic Areas - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 33: Liposomes in Other Therapeutic Areas - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Europe European Market Analysis- Liposomes Exhibit 34: Liposomes - European Value Market Estimations & Predictions (2005 - 2015) in US$ Million Analysis by Geographic Region Liposomal Therapeutics Market Analysis- Liposomal Therapeutics Exhibit 35: Liposomal Therapeutic - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 36: Liposomal Therapeutic - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Liposomal Cosmetics Market Analysis- Liposomal Cosmetics Exhibit 37: Liposomal Cosmetic - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 38: Liposomal Cosmetic - European Value Market Shares (2009 & 2015) by Geographic Region Germany, United Kingdom, France, and Rest of Europe Other Market Analysis- Other Applications of Liposomes Exhibit 39: Other Applications of Liposomes - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 40: Other Applications of Liposomes - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Therapeutic Analysis by Geographic Region Antifungal Market Analysis- Liposomal Antifungal Drugs Exhibit 41: Liposomal Antifungal Drugs - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 42: Liposomal Antifungal Drugs - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Anticancer Market Analysis- Liposomal Anticancer Drugs Exhibit 43: Liposomal Anticancer Drugs - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 44: Liposomal Anticancer Drugs - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Ophthalmic Market Analysis- Liposomal Ophthalmics Exhibit 45: Liposomal Ophthalmic - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 46: Liposomal Ophthalmic - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Other Market Analysis- Liposomes in Other Therapeutic areas Exhibit 47: Liposomes in Other Therapeutic Areas - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 48: Liposomes in Other Therapeutic Areas - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Asia-Pacific Asia-Pacific Market Analysis- Liposomes Exhibit 49: Liposomes -Asia-Pacific Value Market Estimations & Predictions (2005 - 2015) in US$ Million Analysis by Geographic Region Liposomal Therapeutics Market Analysis- Liposomal Therapeutics Exhibit 50: Liposomal Therapeutic - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 51: Liposomal Therapeutic - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Liposomal Cosmetics Market Analysis- Liposomal Cosmetics Exhibit 52: Liposomal Cosmetic - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 53: Liposomal Cosmetic - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Other Market Analysis- Other Applications of Liposomes Exhibit 54: Other Applications of Liposomes - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 55: Other Applications of Liposomes - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Therapeutic Analysis by Geographic Region Antifungal Market Analysis- Liposomal Antifungal Drugs Exhibit 56: Liposomal Antifungal Drugs - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 57: Liposomal Antifungal Drugs - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Anticancer Market Analysis- Liposomal Anticancer Drugs Exhibit 58: Liposomal Anticancer Drugs - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 59: Liposomal Anticancer Drugs - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Ophthalmic Market Analysis- Liposomal Opthalmics Exhibit 60: Liposomal Ophthalmic - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 61: Liposomal Ophthalmic - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Other Market Analysis- Liposomes in Other Therapeutic areas Exhibit 62: Liposomes in Other Therapeutic Areas - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific in US$ Million Exhibit 63: Liposomes in Other Therapeutic Areas - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, China, Japan and Rest of Asia-Pacific Rest of World Rest of World Market Analysis- Liposomes Exhibit 64: Liposomes - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Analysis by Analysis by Application Liposomal Therapeutics Market Analysis- Liposomal Therapeutic Exhibit 65: Liposomal Therapeutic - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Liposomal Cosmetics Market Analysis- Liposomal Cosmetic Exhibit 66: Liposomal Cosmetic - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Other Market Analysis- Other Applications of Liposomes Exhibit 67: Other Applications of Liposomes - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Liposomal Therapeutic Analysis Antifungal Market Analysis- Liposomal Antifungal Drugs Exhibit 68: Liposomal Antifungal Drugs - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Anticancer Market Analysis- Liposomal Anticancer Drugs Exhibit 69: Liposomal Anticancer Drugs - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Ophthalmic Market Analysis- Liposomal Ophthalmics Exhibit 70: Liposomal Ophthalmic - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Other Market Analysis- Liposomes in Other Therapeutic areas Exhibit 71: Liposomes in Other Therapeutic Areas - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million III. MARKET DYNAMICS Market Overview Liposomal Cosmetics Industry Liposomal Neutraceuticals Drug Delivery Market Liposomal Antifungal Drugs Global Market Analysis Exhibit 72: Liposomes - Global Value Market Estimations & Predictions (2005- 2015) by Geographic Region for North America, Europe, Asia-Pacific, and Rest of World in US$ Million Exhibit 73: Liposomes (2009 & 2015) - Global Value Market Shares (2009 & 2015) for North America, Europe, Asia-Pacific, and Rest of World Analysis by Application Exhibit 74: Liposomes - Global Value Market Estimations & Predictions (2005- 2015) by Application for Therapeutics, Cosmetics and Other in US$ Million Exhibit 75: Liposomes (2009 & 2015) - Global Value Market Shares (2009 & 2015) for Therapeutics, Cosmetics and Other Exhibit 76: Liposomes - Global Value Market Estimations & Predictions (2005- 2015) by Therapeutic Area for Antifungal, Anticancer and Ophthalmic and Other in US$ Million Exhibit 77: Liposomes (2009 & 2015): Global Value Market Shares (2009 & 2015) of Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Major Companies in Liposomes Market Advanced Biomedical Ltd. (UK) Arboretum Skincare (USA) Luye Pharma Group Ltd. (China) Avanti Polar Lipids, Inc. (USA) Azaya Therapeutics, Inc. (USA) More… Major Activities in Liposomes Market Merck Buys Stimuvax Vaccine from Oncothyreon Celsion Inks Deal with Yakult Honsha of Japan US FDA Approves PharmaEngine’s Phase II Study of PEPO2 in Pancreatic Cancer Tekmira Pharma unites with Protiva Biotherapeutics Novosom receives patents for RNAi-Delivering Smarticles(R) in the US and Europe Zydus Cadila introduces Nudoxa for cancer therapy… ImmunoVaccine Technologies signs licensing agreements with Pfizer Animal Health for potential animal vaccine usage… PROTIVA licenses SNALP to Merck… VELCADE® and DOXIL® approved by FDA as a combination treatment for Relapsed or Refractory Multiple Myeloma… Merck KGaA and Biomira revise their collaboration terms related to supply of Stimuvax (R) SRI International enters into contract with Taiwan Liposome Company for preclinical investigations of a new atineoplastic drug developed by TLC Terumo and Yakult introduce liposomal formulation use in an anticancer therapy Biomira purchases ProIX Pharmaceuticals Corporation Hana Biosciences gets license to use three-targeted atineoplastic drug candidates developed by Inex Pharmaceuticals More… Regional Market Analysis North America Market Analysis Exhibit 78: Liposomes - North American Value Market Estimations & Predictions (2005 -2015) in US$ Million Exhibit 79: List of Major Companies in North America Analysis by Geographic Region Exhibit 80: Liposomes - North American Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States and Canada in US$ Million Exhibit 81: Liposomes - North American Value Market Shares (2009 & 2015) by Geographic Region for United States and Canada Analysis by Application North American Market Analysis- Application Exhibit 82: Liposomes - North American Value Market Estimations & Predictions (2005 -2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 83: Liposomes - North American Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 84: Liposomes - North American Value Market Estimations & Predictions (2005 -2015) by Therapeutic Area for Antifungal, Anticancer and Ophthalmic and Other in US$ Million Exhibit 85: Liposomes (2009 & 2015): North American Value Market Shares (2009 & 2015) for Therapeutic for Antifungal, Anticancer, Ophthalmic and Other North American Liposomes Market by Country United States United States Market Analysis Lipid based delivery agents in cosmetics Analysis by Application Exhibit 86: Liposomes - United States Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 87: Liposomes - United States Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 88: Liposomes - United States Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 89: Liposomes - United States Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Canada Canadian Market Analysis Liposomes in cosmetics Analysis by Application Exhibit 90: Liposomes - Canadian Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 91: Liposomes - Canadian Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 92: Liposomes - Canadian Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 93: Liposomes - Canadian Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Europe European Market Analysis Market Analysis Exhibit 94: Liposomes - European Value Market Analysis Estimations & Predictions (2005 - 2015) in US$ Million Exhibit 95: List of Major Companies in the Europe Analysis by Geographic Region Exhibit 96: Liposomes - European Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe in US$ Million Exhibit 97: Liposomes - European Value Market Shares (2009 & 2015) by Geographic Region for Germany, United Kingdom, France, and Rest of Europe Analysis by Application Exhibit 98: Liposomes - European Value Market Estimations & Predictions (2005 -2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 99: Liposomes - European Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 100: Liposomes - European Value Market Estimations & Predictions (2005 -2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 101: Liposomes (2009 & 2015): European Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other European Liposomes Market by Country Germany German Market Analysis Analysis by Application Exhibit 102: Liposomes - German Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 103: Liposomes - German Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 104: Liposomes - German Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 105: Liposomes - German Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other The United Kingdom UK Market Analysis Analysis by Application Exhibit 106: Liposomes - United Kingdom Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 107: Liposomes - United Kingdom Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Exhibit 108: Liposomes - United Kingdom Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 109: Liposomal (2009 & 2015): United Kingdom Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other France French Market Analysis Analysis by Application Exhibit 110: Liposomes - French Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 111: Liposomes - French Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 112: Liposomes - French Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 113: Liposomes (2009 & 2015): French Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Rest of Europe Rest of Europe Market Analysis Analysis by Application Exhibit 114: Liposomes - Rest of Europe Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 115: Liposomes - Rest of Europe Value Market Shares (2009 & 2015) of by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Pharmaceutical Market armed with liposomes to combat fungal infections: Exhibit 116: Liposomes - Rest of Europe Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 117: Liposomes (2009 & 2015): Rest of Europe Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Asia-Pacific Market Analysis Exhibit 118: Liposomes - Asia-Pacific Value Market Estimations & Predictions (2005 - 2015) in US$ Million Exhibit 119: List of Major Companies in Asia-Pacific Analysis by Geographic Region Exhibit 120: Liposomes - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Geographic Region for Australia, Japan, China and Rest of Asia-Pacific in US$ Million Exhibit 121: Liposomes - Asia-Pacific Value Market Shares (2009 & 2015) by Geographic Region for Australia, Japan, China and Rest of Asia-Pacific Analysis by Application Exhibit 122: Liposomes - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 123: Liposomes Market - Asia-Pacific Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 124: Liposomes - Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 125: Liposomes - Asia-Pacific Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Asia-Pacific Liposomes Market by Country Australia Australian Market Analysis Analysis by Application Exhibit 126: Liposomes - Australian Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 127: Liposomes - Australian Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 128: Liposomes - Australian Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 129: Liposomes - Australian Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Japan Japanese Market Analysis Analysis by Application Exhibit 130: Liposomes - Japanese Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 131: Liposomes - Japanese Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 132: Liposomes - Japanese Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 133: Liposomes - Japanese Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other China Chinese Market Analysis Analysis by Application Exhibit 134: Liposomes - Chinese Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 135: Liposomes - Chinese Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 136: Liposomes - Chinese Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 137: Liposomes - Chinese Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Rest of Asia-Pacific Rest of Asia-Pacific Market Analysis Analysis by Application Exhibit 138: Liposomes - Rest of Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 139: Liposomes - Asia-Pacific Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 140: Liposomes - Rest of Asia-Pacific Value Market Estimations & Predictions (2005 -2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 141: Liposomes - Asia-Pacific Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Rest of World Rest of World Market Analysis Exhibit 142: Liposomes - Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million Exhibit 143: List of Major Companies in Rest of World Analysis by Application Exhibit 144: Liposomes - Rest of World Value Market Estimations & Predictions (2005-2015) by Application for Therapeutic, Cosmetic and Other in US$ Million Exhibit 145: Liposomes - Rest of World Value Market Shares (2009 & 2015) by Application for Therapeutic, Cosmetic and Other Analysis by Therapeutic Area Exhibit 146: Liposomes - Rest of World Value Market Estimations & Predictions (2005-2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 147: Liposomes - Rest of World Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other IV. PRODUCT/TECHNOLOGY RESEARCH Introduction Liposomes Growth Trends – Global Markets Liposomes Classification of Liposomes Structure and Biophysical Properties of Liposomes Cross-Section of a Living Cell Membrane Comprising Phospholipids Measurement of Liposomes Characteristics of Liposomes Properties of Liposomes Properties of Liposomes Formation and Functions of Liposomes 1. Liposome – Constitution, Activities and Improvements a) C-Terminal Substitution of Amino Acids/Peptides b) Features of N-Linked Glycosylation c) Role of Ligands in Liposome therapy d) Techniques used for forming stable Liposomes 2. Liposome- Understanding Various Effects on Liposomal Membrane a) Effects of Bilayer Lipid Membrane (BLM) stretch on N-Methyl-D- Aspartate (NMDA) b) Effects of Fusion process on Liposomes membrane c) Effects of Stimuli Receptive, Protein & Polymer on Liposome Membranes d) Effects of Melittin-Induced Membrane Fusion on Liposome Membranes Analysis by Geographic Region Liposomal Therapeutics Medication using Liposomes 1. Liposomes as a Drug Carrier for the Treatment of Malaria 2. Protection against Plasmodium Berghei by – Suppressing Parasitemia using Liposome Adhered Recombinant Human Tumor Necrosis Factor 3. Treatment of Mice Infected with Salmonella Dublin using Liposome based Gentamicin 4. Liposomal Delivery in Dental Treatment Significance of Liposomes in Field of Medicine 1. Liposomal Formulations Used in Medical Practice 2. Incorporation of Allergen Extracts into Freeze-Dried Multilamellar Liposomes and its Standardization 3. Allergen Presentation for the Treatment of Allergic Diseases Using Liposomes as Carriers 4. Anti Inflammatory Effect of Targeted Liposomal Therapy 5. Targeted Delivery of Steroids to the Sites of Inflammation using Liposomes 6. Efficacy of Liposomal Drugs in the Treatment of Leishmaniasis 7. Application of Liposomes in Treatment of Pulmonary Disorders 8. Manipulation of Functions of Macrophages using Liposomes 9. Application of Liposomes to combat Fungal Infections 10. Lipid-anchored PEG sterically stabilized pH-sensitive liposomes 11. Application of Liposomes as Chelating Agents and its Mechanism of Action Cancer Treatment using Liposomes Targeting the Tumor using Stealth Liposomes Improved Therapeutic Responses in Murine Models Treatment of Breast Cancer Using Delivery of Drug by Liposomes Ovarian Cancer and Liposomal Doxorubicin Cancer Treatment with Cisplatin Encapsulated Nanoliposomes Brain Cancer Diagnosis and Treatment Using Nanomedicine Attacking the Cancer Tissue with Heat Sensitive Liposomes Anti-PSMA-Liposome-Complex in Cancer Therapy Liposomal-Delivery and Efficacy of Photodynamic-Therapy Application of Liposomes for Drug Delivery Development of ‘Intelligent’ Liposomes to Accomplish Effective Drug Delivery in Medical Applications Use of Liposomal Formulation in Developing Therapeutic Drugs to Enhance Antibacterial Activity Application of Liposome/Anthraquinone Drug Composition in Treatment of Neoplasm Cases Application of Liposomes as a Vaccine Entrapment and Delivery System Liposome Carriers in Chemotherapy of Leishmaniasis Application of Elastic Vesicles as Effective Transdermal Drug Delivery Systems Application of Phospholipid Liposomes in Healing Post Menopausal Mood Disorders Role of Liposomes in Drug Delivery & Application of This Concept in Pharmacokinetics Introduction to the Concept of Pharmacokinetics Basic Models to Explain Pharmacokinetic Process Various Factors Affecting the Liposome Pharmacokinetics Size of Liposome Dosage of Liposome Lipid Composition of Liposome Liposomes Preparation 1. Convectional Process 2. Sonication Process 3. The High-Pressure Extrusion Process 4. The Solubilisation and Detergent Removal Process 5. The Reverse Phase Evaporation Method B. The Pharmaceutical Preparation: Processes Liposomal Cosmetics Liposomes as Carriers in Cosmetics Using Liposomes for Skin Care Using Liposomes for Topical Drug Delivery About Natural Liposomes Method for Using Lyophilized Liposomes for Delivering Skin Treating Agents Detailed Description of Drug Delivery System Using Freeze-Dried Liposomes A Study Using Confocal Laser Scanning Microscopy finds that Hydrophilic Agents Exhibits Greater Levels of Skin Penetration Whether They are Encapsulated in Liposomes or Present in Non-Encapsulated form with Liposomes Stabilizing Liposomes for Detergent Medium Chemical Composition and Physiochemical Characteristics of Liposomes Conducive For Skin Care and Treatment Effectiveness of Ascorbyl Palmitate Encapsulated in Freeze-Dried Liposomes Effectiveness of Lyophilized Liposomes in Delivery of Drugs for Treating Skin Using Confocal Laser Scanning Microscopy to Understand Reactions between Human Skin and Liposomes under Laboratory Conditions – A Plastic Surgery Investigation Collagen Sponge’s Anti-Pseudomonal Reaction with Liposome Encapsulated Polymyxin B – A Plastic Surgery Research Other Liposome Applications Other Uses of Liposomes Liposomes in Genetic Engineering Application of Functional Liposomes Applications of Size and Zeta Potential Method of Inhibiting Viral Reproduction Using Non-Phospholipid, Paucilamellar Liposomes Liposomes – Applications in Protein-Lipid Interaction Preparation of Liposomal Products 1. Method for Liposomes Preparation 2. Methods of Encapsulation of Solute into Liposomes 3. Ensuring Stability of Liposomal Products 4. Liposome Production with a Mini-Lab High-Pressure Homogenizer 5. Method to Produce Unilamellar Liposomal Vesicles Using Highly Active Ingredients 6. Process of Producing Liposomes Having Larger Aqueous Phase and More Encapsulating Capacity by Reverse-Phase Evaporation 7. Submicron Unilamellar Vesicles from Lyophilization of Double Emulsions 8. Producing Liposomes Using Spray-Drying Technique 9. Salient Features of a Commercially Available Liposome Spray 10. Large-Scale Production of Liposomes Using Spray-Drying Technology 11. Preparation of Liposomes by Lyphilisation of Monophase Solutions 12. Mass Production Lipid Powder Containing Liposomes and Encapsulating Material 13. Process for Producing Liposome and Lipid Complex Formulations 14. Process of Obtaining Liposomes from Membrane of Milk Fat Globule Using Microfluidizer 15. Process for Producing Proteoliposomes 16. Producing Liposomes Capable of Encapsulating Chitosan Nanoparticles and Studying their Behavior 17. Producing Liposomes for Encapsulating Tumor Necrosis Factor and Studying their Behavior 18. Preparation of Heat Sensitive Lipid Vesicles from Natural Lipid Molecules for Multimodality Cancer Treatment 19. Controlled Procedure for the Preparation of Liposomes 20. Mechanochemical Method for the Preparation of Liposomes for Encapsulation of Food Materials Using Lecithins 21. Supercritical Carbon Dioxide Procedure 22. A Simple Procedure for the Preparation of Liposomes and their Pharmaceutical Applications 23. Characterization and Preparation of Giant Liposomes in Various Physiological Salt Solutions 24. Development of Liposomes which are Used In the study of Sphingolipid Segregation in Membrane Model Systems 25. Glycolipid-Bearing Unilamellar and Multilamellar Lipid Vesicles Preparation and Standardization Liposomes in Cancer Treatment a. Liposomal Drug Delivery-- Hyperthermia Mediated b. Drug-Filled Liposomes for Tumors c. Liposomes that are Tumor-Targeted make Clinical Headway d. Chemotherapy that is Targeted e. Cancer Therapy and Drug Delivery f. Repression of Tumor Metastasis by Liposomes Comprising of Glyco-Replica Peptides g. Cancer and Boron Neutron Capture Therapy Global Market for Liposomal Therapeutic Products by Geographic Regions Exhibit 148: Liposomal Therapeutic Products - Global Value Market Estimations & Predictions (2005- 2015) by Therapeutic for Antifungal, Anticancer, Ophthalmic and Other in US$ Million Exhibit 149: Liposomal Therapeutic Products - Global Value Market Shares (2009 & 2015) by Therapeutic Area for Antifungal, Anticancer, Ophthalmic and Other Various Diseases- Role of Liposomes Liposomal Therapeutic Products Drug Delivery Using Liposomes Liposomal Drug Delivery Systems – Clinical Applications Systemic and Mucosal Vaccination Macrophage Activation Gastric Mucoadhesion The Potential of Liposomes in Oral Drug Delivery Use of Liposomes for Directed Drug Delivery against Entamoeba Histolytica Use of Liposomes in Topical Drug Delivery Liposomal Drug Delivery System from Laboratory to Clinic Antifungal Developments and Trends in Liposome Drug Delivery Systems Application of Liposomal Amphotericin B in Bone Marrow Transplantion Liposomal amphotericin B Anticancer Liposomal Anticancer Drugs Anticancer Drugs Doxorubicin Liposomal Doxorubicin Pegylated Liposomal Doxorubicin Liposomal Daunorubicin Ophthalmic Other Application of Liposomes for Drug Delivery 1. Development of ‘Intelligent’ Liposomes to Accomplish Effective Drug Delivery in Medical Applications 2. Use of Liposomal Formulation in Developing Therapeutic Drugs to Enhance Antibacterial Activity 3. Application of Liposome/Anthraquinone Drug Composition in Treatment of Neoplasm Cases 4. Application of Liposomes as a Vaccine Entrapment and Delivery System 5. Liposome Carriers in Chemotherapy of Leishmaniasis 6. Application of Elastic Vesicles as Effective Transdermal Drug Delivery Systems 7. Application of Phospholipid Liposomes in Healing Post Menopausal Mood Disorders Liposome as an Imaging Tool 1. Liposomes used in Radiopharmaceuticals 2. The Use of Liposome-Mediated Radiotherapeutics inside Avascular Tumor Spheroids 3. Estimation of the Effect of Hyperthermia on Intratumoral Doxil Extravasation Using Tracer Dose of Technetium-99m-Labeled Liposome 4. Liposomes as Carriers for Targeting Radiopharmaceuticals into Tumor 5. Ultrasonic Imaging Using Liposomes as Contrast Agents 6. Local Drug Delivery of Temperature Sensitive Liposomes Using Focused Ultrasound 7. Ultrasonic Imaging Using Gas Filled Liposomes as Contrast Agents 8. Labeling of Liposomes Using 99m Tc 9. Effect of Drug Delivery of Heated Liposome Visualized In vivo through Magnetic Resonance Imaging 10. Ultrasound-Guided Liposomes Assisted Imaging for Targeted Drug/Gene Therapy 11. Diagnostic Liposomal Compositions for Augmenting NMR Imaging Liposomes as Drug Delivery Tools 1. Plarosomes-- Liposomal Drug Delivery 2. Improvements in Liposomal Drug Delivery Systems 3. The Capability of Polysaccharide Anchored Liposomes in Immunization, Targeting and Drug Delivery Innovations in Liposome Research Progresses in Liposome Research Utility of Long-circulating Liposomes Using Liposomal Amphotericin B Influence of Electrical Fields on Liposomes Aminoglycoside- Encapsulated Lipsomes Merits and Demerits of Conventional Liposomes Utility of Liposome Encapsulated Hemoglobin (LEH) in rats Liposome Vaccines DNA Induced Liposomes Liposomes with Fibrinogen Coating Liposomes – The Outlook V. CORPORATE DIRECTORY VI. PATENTS INFORMATION |